Sign In
Buy IDXG
$1.75
-0.0100 (-0.568%)
At Close: Jun 03, 2026
Maxim Group Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)
11:47am, Friday, 01'st May 2020
Maxim Group analyst Jason McCarthy maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today. The company’s shares
H.C. Wainwright Keeps a Buy Rating on CareDx (CDNA)
11:22am, Friday, 01'st May 2020
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on CareDx (CDNA), with a price target of $40.00. The company's shares
H.C. Wainwright Keeps a Buy Rating on CareDx (CDNA)
11:22am, Friday, 01'st May 2020
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on CareDx (CDNA – Research Report),
Analysts' Top Healthcare Picks: Alimera (ALIM), Seattle Genetics (SGEN)
11:22am, Friday, 01'st May 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alimera (ALIM) and Seattle Genetics (SGEN) with bullish
Analysts’ Top Healthcare Picks: Alimera (ALIM), Seattle Genetics (SGEN)
11:22am, Friday, 01'st May 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alimera (ALIM
Maxim Group Gives a Hold Rating to Gilead Sciences (GILD)
05:12pm, Thursday, 30'th Apr 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Hold rating to Gilead Sciences (GILD). The company's shares closed last Thursday at
Maxim Group Gives a Hold Rating to Gilead Sciences (GILD)
05:12pm, Thursday, 30'th Apr 2020
In a report released today,
Jason McCarthy
from Maxim Group assigned a
Hold
rating to Gilead Sciences (
GILD
–
Research Report
). The company’s shares closed last Thursday at $81.90, close to its
Immutep (IMMP) Receives a Buy from Maxim Group
02:46pm, Thursday, 30'th Apr 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Immutep (IMMP), with a price target of $2.00. The company's shares
Immutep (IMMP) Receives a Buy from Maxim Group
02:46pm, Thursday, 30'th Apr 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Immutep (IMMP – Research Report),
Athenex (ATNX) Receives a Buy from Oppenheimer
02:24am, Thursday, 30'th Apr 2020
In a report released yesterday, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX), with a price target of $23.00. The company's
Athenex (ATNX) Receives a Buy from Oppenheimer
02:24am, Thursday, 30'th Apr 2020
In a report released yesterday, Kevin DeGeeter from Oppenheimer maintained a Buy rating on Athenex (ATNX – Research Report), with
Atossa Genetics (ATOS) Gets a Buy Rating from Maxim Group
05:16pm, Tuesday, 28'th Apr 2020
Maxim Group analyst Jason McCarthy assigned a Buy rating to Atossa Genetics (ATOS) today and set a price target of $4.00. The company's shares closed last
Atossa Genetics (ATOS) Gets a Buy Rating from Maxim Group
05:16pm, Tuesday, 28'th Apr 2020
Maxim Group analyst Jason McCarthy assigned a Buy rating to Atossa Genetics (ATOS – Research Report) today and set a
Roche Q1 Sales Call Key Takeaways
12:39pm, Tuesday, 28'th Apr 2020
We highlight main points from Roche Q1 conference call and summarize key takeaways for investors. Pharma is showing resilience in the face of intensive biosimil
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:12am, Tuesday, 28'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Selecta Biosciences (SELB), CytoDyn (CYDY) and Sutro
